Anti-VSIV Matrix Polyclonal Antibody from ProteoGenix; catalogue ARO-A22425; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-VSIV Matrix Polyclonal Antibody – your go-to solution for efficient virus detection and analysis.
This highly specific antibody is designed to target the VSIV (Virus-Specific Integrin Binding) matrix protein, a key component of viral infection and replication. By binding to this protein, the Anti-VSIV Matrix Polyclonal Antibody enables accurate detection and analysis of various viruses, making it an essential tool for biotech researchers.
The main application of this antibody is in virus detection and identification, particularly in cases where traditional methods may not be effective. With its high sensitivity and specificity, the Anti-VSIV Matrix Polyclonal Antibody can detect even low levels of viral presence, providing reliable and precise results.
In addition to its use in virus detection, this antibody has also shown promising results in experimental studies. It has been used in various research projects to study the mechanisms of viral infection and replication, as well as to develop new antiviral therapies. Its versatility and effectiveness make it a valuable asset for any biotech laboratory.
When it comes to experimental use cases, the Anti-VSIV Matrix Polyclonal Antibody has been successfully used in both in vitro and in vivo studies. Its ability to accurately target the VSIV matrix protein has been proven in a variety of cell lines and animal models, making it a versatile tool for different research needs.
In summary, the Anti-VSIV Matrix Polyclonal Antibody is a powerful and reliable solution for virus detection and analysis. Its unique ability to target the VSIV matrix protein sets it apart from other antibodies, making it a valuable addition to any biotech researcher’s toolkit. Don’t miss out on this essential tool for your virus-related studies – order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22425. For research use only.
Target: matrix (M) protein, matrix (M) protein; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| matrix (M) protein, matrix (M) protein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
